2nd International Conference on Biotechnology and Bioengineering, a Hybrid Event scheduled from October 24-25, 2024, Paris, France. They cordially invite competitors from all corners of the globe to showcase their expertise, talents, and research in the realm of biotechnology.This year, our focus lies on "Emerging Technologies and Research in Biotechnology."Participants will have the opportunity to participate in oral presentations, poster sessions, and video presentations spanning over 18 tracks and sessions, delving into various faces of biotechnology.

Read on biotechnologyconferences.com

The 4th Annual Extractables & Leachables Summit 2024 focuses on the critical assessment phase in biopharmaceutical development—evaluating extractables and leachables. Regulatory bodies emphasize understanding pharmaceutical interactions with container closure systems, drug delivery devices, and bioprocess manufacturing. Our virtual conference unites scientists, toxicologists, and E&L managers to share insights on analytical methods, regulatory updates, risk-based E&L programs, chemical characterization, and toxicological risk assessment. Discussions cover thresholds, medical device materials, ISO 10993-18, and tailored systems for diverse products. Join us to explore cutting-edge approaches in analysis and testing, mitigating E&L risks, and ensuring patient safety and product integrity.

 [Read on www.uventia.com](https://www.uventia.com/event/4th-annual-extractables-leachables-summit-2024/)

Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech.

Final Agenda Now Available Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent tracks. New for 2023 is coverage of targeting transcription factors, plus greatly expanded coverage of protein degraders, molecular glues, and artificial intelligence for early drug discovery. Speakers from industry will once again be strongly represented, including: AbbVie, Amgen, Astex Pharmaceuticals, AstraZeneca, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, GlaxoSmithKline, Janssen, Johnson & Johnson, Merck, Novartis, Pfizer, and more. In addition, featured presentations will be given by the University of Washington's David Baker, Stanford's Gerald Crabtree, Vanderbilt's Stephen Fesik, and UC Berkeley's Daniel Nomura. For maximum savings, reserve your place by March 3. Bring a team to San Diego and save 25% with a Group registration

Read on cii.dryfta.com